Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.3.1.900
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2015
Schedule of share-based compensation expense recognized

                                                                                                                                                                                    

 

 

Year Ended December 31,

 

 

 

2015

 

2014

 

Research and development

 

$

1,460,061 

 

$

1,129,244 

 

General and administrative

 

 

1,966,669 

 

 

1,254,155 

 

​  

​  

​  

​  

Total stock-based compensation

 

$

3,426,730 

 

$

2,383,399 

 

​  

​  

​  

​  

​  

​  

​  

​  

 

Summary of stock option activity

                                                                                                                                                                                    

 

 

Options Outstanding

 

 

 

Number
of Shares

 

Weighted-
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

Balance, December 31, 2013

 

 

2,795,746

 

$

2.52

 

 

8.45

 

Granted

 

 

1,095,042

 

 

6.75

 

 

 

 

Exercised

 

 

(186,687

)

 

0.60

 

 

 

 

Forfeitures

 

 

(129,651

)

 

7.20

 

 

 

 

​  

​  

Balance, December 31, 2014

 

 

3,574,450

 

$

3.75

 

 

8.06

 

Granted

 

 

1,645,960

 

 

7.16

 

 

 

 

Exercised

 

 

(384,033

)

 

2.36

 

 

 

 

Forfeitures

 

 

(206,304

)

 

6.04

 

 

 

 

​  

​  

Balance, December 31, 2015

 

 

4,630,073

 

$

4.98

 

 

7.87

 

​  

​  

​  

​  

Vested or expected to vest at December 31, 2015

 

 

4,488,894

 

$

4.91

 

 

 

 

​  

​  

​  

​  

Exercisable at December 31, 2015

 

 

1,941,347

 

$

3.10

 

 

 

 

​  

​  

​  

​  

 

Schedule of weighted-average assumptions:

                                                                                                                                                                                    

 

 

Year Ended
December 31,
2015

 

Year Ended
December 31,
2014

 

Expected term of options (in years)

 

 

6.2 

 

 

5.8 

 

Risk-free interest rate

 

 

1.7 

%

 

1.8 

%

Expected volatility

 

 

68.5 

%

 

75.9 

%

Dividend yield

 

 

%

 

%

 

Schedule of shares of common stock reserved/available

                                                                                                                                                                                    

At December 31, 2015, the Company has reserved the following shares of common stock for issuance:

Stock options outstanding

 

 

4,630,073 

 

Shares available for future grant under 2013 Plan

 

 

959,354 

 

Employee stock purchase plan

 

 

225,806 

 

Warrants outstanding

 

 

62,800 

 

​  

​  

 

 

 

5,878,033 

 

​  

​  

​  

​  

 

2013 plan  
Schedule of shares of common stock reserved/available

                                                                                                                                                                                    

Available at December 31, 2014

 

 

829,364

 

Authorized

 

 

1,569,646

 

Granted

 

 

(1,645,960

)

Forfeitures/Expirations

 

 

206,304

 

​  

​  

Available at December 31, 2015

 

 

959,354

 

​  

​  

​  

​